APA (7th ed.) Citation

J, R., T, O., H, P., R, D., & P, L. (2024). Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine. Headache, 64(3), 243. https://doi.org/10.1111/head.14681

Chicago Style (17th ed.) Citation

J, Rossignol, Ouimet T, Poras H, Dallel R, and Luccarini P. "Synergistic Effect of Combining Dual Enkephalinase Inhibitor PL37 and Sumatriptan in a Preclinical Model of Migraine." Headache 64, no. 3 (2024): 243. https://doi.org/10.1111/head.14681.

MLA (9th ed.) Citation

J, Rossignol, et al. "Synergistic Effect of Combining Dual Enkephalinase Inhibitor PL37 and Sumatriptan in a Preclinical Model of Migraine." Headache, vol. 64, no. 3, 2024, p. 243, https://doi.org/10.1111/head.14681.